Redefining the future of Botox
Become an ARCHITOX™ provider
What would it mean to double your Botox sales by elevating the level of your results?
The ARCHITOX
Method
What is it?
ARCHITOX™ is a data-driven, advanced *high-dose Botox application method designed to optimize neuromodulator outcomes through precise mapping of muscle bulk and surface area, ensuring maximum efficacy and longevity.
Engineered for an elevated aesthetic, ARCHITOX™ delivers maximum upper-face refinement, balanced brow dynamics, and progressive muscle bulk reduction.
How is it different?
In contrast to traditional Botox application, which adheres to generalized dosing guidelines and injection patterns, ARCHITOX™ employs a precision-based methodology rooted in muscle physiology and mechanics. Unit allocation is determined through the analysis of muscle bulk and surface area—key variables that are not addressed in standard industry protocols.
By definition, high-dose Botox refers to treatments exceeding the regulated optimal dose of 80 units. This advanced approach achieves superior outcomes by not only reducing lines and etched wrinkles but also addressing dynamic imbalances in muscle movement and minimizing muscle bulk over time. The result is a more refined, symmetrical appearance with long-term benefits, including improved treatment longevity and cumulative refinement over time.
Benefits for your patients
Standardized, Predictable Outcomes – By calibrating dosage based on muscle bulk and contraction patterns, ARCHITOX™ eliminates variability, ensuring consistent neuromodulator effects and reducing patient anxiety related to uncertain results.
Optimized Treatment Longevity – The dose-response relationship is customized to individual muscle strength and surface area, prolonging clinical efficacy while minimizing premature metabolic breakdown.
Prevention of Macro-Compensation – Comprehensive mapping of the upper face prevents hyperactivity in untreated muscles, which can result in overcompensation and dysregulated movement patterns.
Prevention of Micro-Compensation – By addressing intra-muscular variability, ARCHITOX™ minimizes localized overactivity within a single muscle group, preventing subtle imbalances that contribute to unnatural facial dynamics.
Sustained Muscle Adaptation – Over time, strategic dosing reduces excessive muscle bulk while preserving functional integrity, leading to a refined yet physiologically balanced result in both male and female patients.
Benefits for your practice
Increase Revenue: Proven to double Botox revenue with current patient base, while a premium method attracts higher-value future clients.
Elevate Client Satisfaction: Deliver optimal outcomes that are predictable.
Increase Trust: Evidence based research combined with predictable outcomes apmplify trust through certainty.
Improve Retention: Higher satisfaction creates pre-booked future appointments.
Boosts Practitioner Confidence: Develops certainty with outcomes and supercharges assessment skills.
Supported by science
High-dose botulinum neurotoxin A (BoNTA) is emerging as a superior approach, with research suggesting that “high-dose” BoNTA may be the optimal dose and that “approved doses…are efficacious, [but] this does not mean they are optimal.” This insight, from High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice (Aesthetic Surgery Journal Open Forum, December 2021), supports innovative methods like ARCHITOX™ which refine high-dose applications to maximize efficacy.
Research Links
I grew my NEW practice EXPONENTIALLY with ARCHITOX
see the results below
PERFORMANCE
Growth Even Through Adversity
2018-2019: Opened my clinic practicing SOME high-dose
2020 - 2021: Changed full practice to ARCHITOX™
Comparing Periods
ARCHITOX™ consistently makes up 70% of total yearly revenue
Pandemic* Appointments
657 Total Appointments
Year 2022
1625 Total Appointments
*Pandemic period = Mar 2020 - Feb 2021
Let the Numbers
TALK
Year 2022
*Growth rate from 2020-2022 = 127.27%
26.5
Weekly Operating Hours
$1.5M
Total Sales for the Year
$909K
Total ARCHITOX Sales for the Year
Elevating results for consumers and confidence for providers
see below
Patient Story
Louise MCLoughlin, Age 37 - Urologist, Specializing in Uro-Oncology, Toronto CA
“There is no comparison between ARCHITOX™ and my previous experiences with Botox. The assessment was comprehensive and in-depth, the treatment areas were specifically marked out, and the rationale for the dose was clearly explained. The attention to detail throughout the assessment and application was incredible… After only a few weeks, the over prominence in my brow area and muscle bulk has already substantially reduced, which I have not had with my previous treatments. Without a doubt, ARCHITOX™ will benefit every person within my demographic considering Botox. My only regret was not discovering this company sooner and wasting time and money with other injectors not using the ARCHITOX™ technique.”
Provider Story
Elyse NP - Owner of Brain & Body Co, Toronto CA
“I reached out to Megan to gain insight into how I could apply her signature “ARCHITOX™ method that utilizes high-dose Botox and a tailored injection pattern. After only 8 hours with Megan, my confidence as a Nurse Practitioner in the medical aesthetics field was immediately heightened! I basically doubled my standard units… I adapted Megan’s technique and have notably benefited from it - not only with increased client satisfaction, but also improvement in my profit margins.”
ARCHITOX drives more than just increasing your Botox revenue…
see below
The ULTIMATE
ARCHITOX Advantage
ARCHITOX™ amplifies trust through certainty. A more trusting patient results in higer conversion rates to fillers.
TRANSFORM your practice with ARCHITOX
